Next Article in Journal
Japanese Prefabricated Housing Manufacturers
Previous Article in Journal
Tethered Swimming: Historical Notes and Future Prospects
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Encyclopedia
Volume 4
Issue 3
10.3390/encyclopedia4030068
encyclopedia-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Entry

Phosphatidyl Inositol 4-Kinases

by
Ravinder Kumar
1,* and
Piyush Kumar
2
1
Department of Clinical Pharmacy and Translational Science, Collage of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38163, USA
2
Epigeneres Biotech Private Limited, Sun Mill Compound, Lower Parel, Mumbai 400013, MH, India
*
Author to whom correspondence should be addressed.
Encyclopedia 2024, 4(3), 1062-1072; https://doi.org/10.3390/encyclopedia4030068
Submission received: 28 May 2024 / Revised: 24 June 2024 / Accepted: 28 June 2024 / Published: 29 June 2024
(This article belongs to the Section Medicine & Pharmacology)
Browse Figure
Review Reports Versions Notes

Definition

:
In recent decades, phosphoinositides (or PIs) have emerged as essential signaling molecules. Despite their low cellular abundance, PIs are found to be involved in various cellular processes, including cell migration, vesicular trafficking, cell cycle regulation, metabolism, cytoskeletal remodeling, autophagy, aging, apoptosis, and cell signaling. Recent studies have shown that aberrant activity of either lipid kinases or phosphatases leads to various medical implications like cancer, diabetes, and microbial infections, suggesting an essential role for these lipid molecules and enzymes in their metabolism. This entry focused on one of the critical enzymes involved in phosphoinositide metabolism: phosphatidyl inositol 4-kinase (PI4-Kinase).

1. Introduction

PI4-Kinase (or phosphatidylinositol 4-kinase) is a vital lipid kinase in cells. It phosphorylates at the fourth hydroxyl position of the inositol ring of PtdIns (phosphatidylinositol), thereby generating PtdIns 4P (phosphatidylinositol 4 phosphate) or PtdIns 4,5 bis phosphate (phosphatidylinositol 4,5 bis phosphate) or PtdIns 3,4,5 triphosphate (phosphatidylinositol 3,4,5 tri phosphate), depending upon substrates [1]. These three products act as important cell-signaling molecules by profoundly affecting cell physiology. Based on biochemical studies and sequence analysis, this enzyme is classified into two families: type-II PtdIns 4-kinases and type-III PtdIns 4-kinases. Both families have two isoforms, known as alpha and beta. PtdIns 4-kinases are found at the plasma membrane (as membrane-bound) in the cytoplasm, Golgi complex, endosomes, endoplasmic reticulum, cellular vesicles, and nucleolus.

2. Phosphatidylinositol

PtdIns are lipid molecules that act as an essential constituent of cellular membranes. PtdIns are present in plasma membranes, membranes of the Golgi complex, endoplasmic reticulum, and synaptic vesicles. PtdIns account for a small percentage of total lipids present in membranes. Although present in minuscule amounts (when compared to other lipids in cell), they play an essential role in the cells. The parent compound from which PtdIns are derived is phosphatidic acid (PA). Various phosphatidylinositol derivatives are generated due to phosphorylation at different positions of the inositol ring by different PtdIns kinases. PtdIns consist of a glycerol backbone, which is esterified at its sn-1 and sn-2 positions to two fatty acid molecules, with phosphate at its sn-3 position. The phosphate group is also esterified with an inositol ring at the D1 position [1]. PtdIns are synthesized in the endoplasmic reticulum [2]. Many proteins interact with phosphatidylinositol or its phosphorylated derivatives. These phosphoinositides have pleiotropic functions in cells. The balance of the PtdIns kinases and phosphatase activities can thus be important in different cell compartments [3]. A detailed description of enzymes involved in PtdIns metabolism is beyond this entry’s scope and can be found elsewhere [4]. The structure of Ptdins is shown in Figure 1.

3. Phosphatidyl Inositol 4-Kinases (PtdIns 4-Kinase)

Phosphatidylinositol 4- kinases phosphorylate at the D4 position of the inositol ring of Ptdlns. Both type-II and type-III phosphatidylinositol 4-kinases phosphorylate at the fourth hydroxyl position of the inositol ring of PtdIns. Genes encoding for PtdIns 4-kinases have been cloned from diverse organisms, namely, Saccharomyces cerevisiae (unicellular eukaryote), Homo sapiens (mammal), and Dictyostelium discoideum [5]. The first PtdIns 4-kinase gene to be cloned was PIKI (Phosphatidyl Inositol Kinase) from S. cerevisiae and encoded for 125 kDa nuclear-associated protein [6]. The second gene encoding PtdIns 4-kinase was also from yeast, STT4 (STaurosporine and Temperature sensitive). STT4 codes for a 200 kDa protein [7]. These enzymes share homology with PtdIns 3-kinases. From mammalian sources, 230 kDa and 92 kDa type-III PtdIns 4-kinases were cloned [8]. Both 230 kDa and 92 kDa PtdIns 4-kinases are inhibited by wortmannin. Two 110 kDa and 210 kDa type-III PtdIns 4-kinases were isolated from the adrenal cortex of bovine [9,10].

4. Type-II PtdIns 4-Kinases

Type-II phosphatidylinositol 4-kinases are inhibited by adenosine but not by wortmannin. Type-II PtdIns 4-kinase is also inhibited by 4C5G monoclonal antibody [11]. Type-II PtdIns α was cloned from rat brain and A431 cell lines (Homo sapiens epithelial carcinoma) and the β isoform from EST of neuroblastoma. Both isoforms phosphorylate PtdIns only. Type-II phosphatidylinositol 4-kinase α has 479 amino acid residues and a molecular mass of 54 kDa. Type-II phosphatidylinositol 4-kinase β has 481 amino acid residues [12,13,14]. The km value of PtdIns and ATP for α isoforms is 28 µM and 54 µM, respectively. The km value of PtdIns and ATP for β isoforms is 21 µM and 65 µM, respectively.

5. Type-III PtdIns 4-Kinases

Type-III PtdIns 4-kinase isolated from a fraction of bovine brain and bovine uterus have molecular masses of 230 kDa and 200 kDa, respectively [15]. Type-III PtdIns 4-kinase with a molecular mass of 76 kDa has been reported from cytoplasm of rat brains cells. Type-III PtdIns 4-kinases have also been reported in the cytoplasm of rat brain and bovine adrenal cortical cells with molecular mass ranging from 92 to 125 kDa [16,17,18]. PtdIns 4-kinase 230 shows insensitivity towards adenosine. Its Km value for ATP is about 300 µM. The activity of this enzyme is reduced to 50% of the maximum value by 200 nM wortmannin [19].

6. Structure and Domains of PtdIns 4-Kinases

Stt4p, type-III PtdIns 4-kinase alpha from rat brain have pleckstrin homology (PH) domain. PtdIns 4-kinase alpha also shows ankyrin repeats, which are implicated in the localization of proteins in the cytosol.
Sequence analysis of alpha and beta forms of type-II PtdIns 4-kinase shows that these two isoforms differ in their first 90 amino acid residues. However, the C-terminal is highly conserved in both forms (about 58% identical and 75% homologous). Both proteins lack conspicuous transmembrane regions. Both forms have cysteine-rich palmitoylation motifs known as the CCPC motif that helps in membrane localization. One proline-rich motif, PXXP, is present only in type-II PtdIns 4-kinase beta. Deletions of the first 90 amino acid residues do not affect the ability of alpha form to associate with the membrane. Deleting the CCPC motif reduces the ability of alpha isoforms to associate with the membrane and reduces catalytic activity. The 96 N-terminal amino acid residues are vital for the membrane association of beta isoforms [20].
Our research has meticulously characterized the minimum catalytic domain of mammalian type-II phosphatidylinositol 4-kinase alpha. We have identified critical amino acid residues that play a pivotal role in catalysis and the enzyme’s specificity for its substrate. A 43-45 kDa fragment at the C-terminal, lacking 92 amino acid residues of the N-terminal region, forms the minimum catalytic core of the alpha form of type-II PtdIns 4-kinase. Even the removal of a few amino acid residues from the C-terminal dramatically reduces catalytic activity. Notably, Lys -152 is involved in the binding of nucleotides, while Asp-307 is believed to function as a catalytic base. Asn-312 and Asp-345 are shown to bind Mg2+. Additionally, Glu-155, Pro-163, and Asp-300 are conserved in the type-II PtdIns 4-kinase class [12]. It is important to mention that the crystal structure of several PtdIns 4-kinases is now available which will make drug discovery more likely [21,22,23,24].

7. Localization of Different PtdIns 4-Kinases

Expression and localization of different PtdIns 4-kinases are cell- and tissue-specific. Even within the cell, the localization of various enzyme forms is specific.

7.1. Localization of Type-II Phosphatidylinositol 4-Kinase

The diversity of PtdIns 4-kinase localization is striking. For instance, type-II PtdIns 4-kinase α is associated with membranes of the endoplasmic reticulum (ER), trans-Golgi network (TGN), and endosomes [25,26]. Similarly, type-II PtdIns 4-kinase β is found in membranes of ER, Golgi complex, in the cytoplasm, and with the plasma membrane. This diversity in localization underscores the complexity and variety of their functions.

7.2. Localization of Type-III Phosphatidylinositol 4-Kinase

Studies carried out with type-III PtdIns 4-kinase α have shown that this enzyme localizes in various cellular organelles like nuclei from rat neuronal cells [27], membranes of ER, mitochondria, and multivesicular bodies [28]. Type-III PtdIns 4-kinase β is present in early Golgi compartments and nuclei. The cellular localization of PtdIns 4-kinases highly depends on the protein’s phosphorylation of various amino acid residues. For example, phosphorylation of type-III PtdIns 4-kinase β on Ser-294 results in its recruitment into Golgi, whereas phosphorylation on Ser-496 or Thr-504 leads to localization of this form inside the nucleus [29]. Type-III PtdIns 4-kinase was found to be localized in the Golgi apparatus and vacuoles [30].

8. Phosphoinositide 4-Phosphatases

The role of phosphoinositide 4-phosphatases is as vital as that of PtdIns 4-kinases. These proteins remove phosphate, which was added by PtdIns 4-kinases. Phosphoinositide 4-phosphatases have the same relationship as PtdIns 3-kinase and PTEN (phosphatase and TENsin homolog deleted on chromosome 10) [31]. Examples of phosphoinositide 4-phosphatases are type-INPP4 alpha (type-I inositol-3,4-bisphosphate 4-phosphatase) [32], TMEM55A (transmembrane protein 55A), and TMEM55B (transmembrane protein 55B). These proteins play a crucial role in PtdIns metabolism.

9. Regulation of Phosphatidylinositol 4-Kinases

9.1. Effect of Polycations

Polylysine and polyornithine stimulate PtdIns 4-kinase and PtdIns 4-phosphate 5-kinase activity in amphibian oocytes [33,34,35,36]. Spermine and spermidine also stimulate PtdIns 4-kinase activity. Essential proteins like cardiotoxins and mastoparan stimulate type-II PtdIns 4-kinase activity [37,38,39].

9.2. Effect of Phosphorylation

Adding IL-1 to human fibroblast and orthovanadate to rat liver membranes increases the PtdIns 4-kinase activity [40]. Overexpression of the HER/neu (human epidermal growth factor receptor) gene in breast cancer cells also increases PtdIns 4-kinase activity [41]. Adding epidermal growth factor (EGF) to A431 cells increases PtdIns 4-kinase activity [42].

9.3. Regulation by Small Molecules

Some proteins, like histones, also regulate the activities of these enzymes. Lipids like PtdIns 4-phosphate and phosphatidylserine are found to inhibit type-II PtdIns 4-kinases, while sphingosine 1-phosphate activates these proteins [43]. Para-chloro mercuribenzoate inhibits type-II PtdIns 4-kinase [44]. Adenosine, AMP, and ADP inhibit type-II PtdIns 4kinase when ATP is depleted in the cell. 9-cyclohexyladenine also inhibits PtdIns 4-kinase activity [45]. Flavonoid-like orobol also inhibits PtdIns 4-kinase activity. 2, 3-dihydroxybenzaldehyde and 2, 3-dihydroxybenzoic acid metabolites from yeast also inhibit PtdIns 4-kinase activity [46]. Quercetin inhibits PtdIns activity like orobol [47]. Sphingosine 1 phosphate is found to stimulate PtdIns 4-kinase activity in blood platelets [48].

9.4. Divalent Cations and Detergents

Metals with valency +2, e.g., Mg and Mn, are required for the activity of PtdIns 4-kinases. Ca2+ inhibits both isoforms of type-II PtdIns 4-kinases [49]. Nonionic detergents like Triton X100 stimulate the activity of type-II PtdIns 4-kinase [50].

10. PtdIns 4-Kinase Involved in Cell Signaling

The process begins with the phosphorylation of phosphatidylinositol in the membrane at the fourth position of the inositol ring by PtdIns 4-kinase. This generates phosphatidyl inositol 4-phosphate, which then acts as a substrate for PtdIns 4-phosphate 5-kinase. The action of PtdIns 4-phosphate 5-kinase converts phosphatidyl inositol 4 phosphate into another phosphorylated derivative of PtdIns, i.e., phosphatidylinositol 4, 5-bisphosphate (PtdIns 4, 5-P2) [51]. PtdIns 4, 5-P2 is then acted upon by PtdIns 3-K, and PtdIns 3, 4, 5-tri phosphate (PtdIns 3, 4, 5-P3) is formed as the product [52,53].
Upon forming PtdIns 3, 4, 5-P3, PDK1 (Pyruvate dehydrogenase kinase 1), and Akt (a Serine/threonine Kinase) translocate. The full activation of Akt requires its phosphorylation at Thr-308 and Ser-473 [54,55]. The cell harbors three isoforms of Akt, namely, Akt1, Akt2, and Akt3 [56]. The activation of Akt leads to the phosphorylation of numerous proteins downstream, which participate in various signaling pathways such as iNOS (nitric oxide synthase), GSK33β (glycogen synthase kinase-3 beta), p21CIP1 (cyclin-dependent kinase inhibitor-p21), p27KIP1 (cyclin-dependent kinase inhibitor-p27), Chk1 (cell cycle checkpoint kinase-1), and CDK1 (cyclin-dependent kinase) [57].
Phosphorylation of GSK3β by activated Akt inactivates GSK3β by phosphorylating it. In its phosphorylated form, GSK3β cannot phosphorylate β-catenin [58]. Hence, the concentration of unphosphorylated β catenin builds up in the cytoplasm. As the concentration of ß catenin builds up in the cytoplasm, the translocation of β-catenin into the nucleus starts. As a result, the level of unphosphorylated β-catenin inside the nucleus increases. Increased levels of unphosphorylated β-catenin inside the nucleus cause the induction of many genes [59] like WISP-1 (WNT1-inducible-signaling pathway protein 1) [60], c-myc [61], TCF [62], c-jun, fra [63], etc. In the presence of inhibitors against Akt or PtdIns 3-kinase, these pathways are affected. Unphosphorylated active GSK3β causes phosphorylation of β-catenin, and phosphorylated β-catenin is degraded in the ubiquitin–proteasome [64].
An increased level of unphosphorylated β-catenin inside the cytoplasm causes a rise in the level of p53 protein. This protein causes the induction of several genes, such as BAX, 14-3-3σ, p21, GADD45 (Growth Arrest and DNA Damage), and FAS [65,66]. The increased level of p53 causes the activation of GSK3β. As a result, β- catenin is phosphorylated, and phosphorylated β-catenin is degraded in the ubiquitin-proteasome, so the level of β-catenin decreases.
Another pathway from PtdIns 4, 5-P2 involves PLC (phospholipase C), which occurs in different isoforms. The action of PLC on PtdIns 4, 5-P2 generates Ins 1, 4, 5-P3, and DAG (diacylglycerol). Ins 1, 4, 5-P3, so formed, causes an increase in the cytoplasmic calcium level (release of calcium from ER lumen). Increased Ca2+ in the cytoplasm causes reorganization of the actin cytoskeleton, which leads to cell migration. Increased calcium levels and DAG cause the activation of another kinase known as protein kinase C (PKC) [67]. PKC phosphorylates Ser or Thr residues of specific target proteins, changing their catalytic activities. Protein kinase C occurs in different isoforms inside the cell. Elevated activity of PKC is found to be associated with several types of malignancies [68,69].

11. Proteins Interacting with Phosphoinositides

11.1. Gelsolin

Gelsolin’s interaction with PtdIns 4,5P2 at the barbed end of the actin filament is pivotal. As a crucial capping protein of actin filaments, this interaction leads to the disassembly of the actin-gelsolin complex, a process that has significant implications for actin filament dynamics and cellular functions [70].

11.2. CapZ

It is also an essential capping protein, like Gelsolin. The binding of PtdIns 4,5P2 to capZ inhibits its capping activity [71].

11.3. α-Actinin

It is a crucial actin cross-linking protein. It is present at different cell locations, including cell–cell and cell–matrix contact sites, lamellipodia, and the stress-fiber-dense region [72].

11.4. Profilin

It is an actin-binding protein that regulates the polymerization and depolymerization of actin filaments. Apart from binding to actin, profilin also binds to other cytoskeletal proteins, which link actin to extracellular membrane proteins or other molecules [73].

11.5. Vinculin

The binding of vinculin to PtdIns 4, 5-P2 triggers a significant conformational change in vinculin. This change exposes the binding sites for actin and talin, leading to the stabilization and promotion of actin binding to the membrane. This clear cause-and-effect relationship underscores the importance of these interactions in cellular processes [74,75].

12. Protein Interactors of Phosphatidylinositol 4-Kinases

It is important to mention that PtdIns 4-kinase interacts with several proteins, including 14-3-3 proteins involved in several processes [76,77,78,79,80]. Identification of PI4K-interacting proteins will be important as this will help us to better understand the biology of this enzyme. For example, in yeast, Stt4 interact with more than 30 proteins physically [81]. Similarly, another yeast PI4K, PIk1 also interact physically with around 30 proteins [82]. Interaction of PI4K with proteins showed some degree of specificity. Studies involved checking human PI4K protein interactome is missing but may be possible in future.

13. Functions of Phosphatidylinositol 4-Kinases

Phosphatidylinositol 4-kinases, in addition to generating second messengers, actively perform diverse roles within cells. These roles are closely tied to their specific cellular locations. For instance, PtdIns 4P and PtdIns 4,5P2 actively participate in actin cytoskeletal reorganization and maintain the integrity of yeast cell walls [83]. The downregulation of PtdIns 4-kinase III α, in conjunction with PtdIns 3-kinase, actively leads to developmental defects in the pectoral fin of zebrafish [84]. PtdIns 4-kinase III α actively maintains the phosphoinositide pool at the plasma membrane [85]. Furthermore, it actively participates in the replication of the hepatitis C virus (HCV) [86]. This enzyme is also actively involved in endocytosis, exocytosis, vesicular trafficking, and cell secretion, demonstrating its active and diverse roles.
Loss of phosphatidylinositol 4-kinase II alpha is associated with the degeneration of axons in aged mice [87]. PtdIns 4-kinase II α is implicated in tumor growth and angiogenesis by regulating HIF-1α (Hypoxia-inducible factor) [88]. It is observed that type-II PtdIns 4-kinase is important in wnt signaling in Xenopus embryos, and it is also believed to interact with Dvl [89,90]. Some studies also pointed towards the association of PtdIns 4-kinase II α with cellugyrin-positive Glut 4 vesicles [91]. Phosphatidylinositol 4-kinase type-II alpha is also believed to be necessary for endosomal trafficking and degradation of activated epidermal growth factor receptors [92]. PtdIns 4-kinase is also associated with the adaptor protein (AP) complex, which plays a vital role in the trafficking of cellular vesicles [93]. PtdIns 4-kinase also plays a crucial role in activating phospholipase D [94]. In yeast type-II, PtdIns 4-kinase lsb6 deletion impairs endosome motility and sorting, supporting their role in endocytic pathways [95]. Inhibition of type-II phosphatidylinositol 4-kinase activities by resveratrol correlates with reducing Jurkat cell adhesion to fibronectin or matrigel-coated surfaces [96]. Type-II phosphatidylinositol 4-kinase also enters Listeria monocytogenes in mammalian cells [97]. Inhibition by monoclonal antibodies’ type-II phosphatidylinositol 4-kinase activity inhibits phagocytosis and neutrophil respiratory burst [98]. Inhibition of type-II phosphatidylinositol 4-kinase in RBL2H3 cells (Rat Basophilic Leukemia) is associated with inhibition of β hexosaminidase release [99]. Overexpression of type-II phosphatidylinositol 4-kinase α enhances FcεRI-mediated degranulation in RBL2H3 cells [100]. Inhibition of chromaffin granule-associated phosphatidylinositol 4-kinase activity impairs stimulated secretion [101]. Diverse roles or functions of phosphatidylinositol 4-kinase are highlighted in Table 1.

14. Conclusions

From the perspectives discussed above, despite their low abundance, phospholipids and the enzymes involved in their metabolism profoundly impact cell physiology. These enzymes and lipids are involved in diverse cellular pathways and functions. Apart from their involvement in normal cellular physiology, these enzymes are now found to be involved or associated with diverse clinical or medical conditions, ranging from cancer to neurological diseases to microbial infection. Targeting these enzymes can be the right strategy in developing drugs.

Author Contributions

R.K. conceived the idea and wrote the first draft. P.K. edited and modified the draft. R.K. also responded to reviewers’ comments. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

RK is grateful to University of Tennessee Health Science Center Memphis, TN, USA, for providing the space and other necessary facilities needed for the completion of this manuscript.

Conflicts of Interest

Piyush Kumar is the employee of Epigeneres Biotech Private Limited. The authors declare no conflicts of interest.

References

  1. Sasaki, T.; Takasuga, S.; Sasaki, J.; Kofuji, S.; Eguchi, S.; Yamazaki, M.; Suzuki, A. Mammalian phosphoinositide kinases and phosphatases. Prog. Lipid Res. 2009, 48, 307–343. [Google Scholar] [CrossRef]
  2. Tom, D.B.; Katan, M. Phosphoinositide signaling in cancer: Beyond PI3K and PTEN. Nat. Rev. 2010, 10, 342–352. [Google Scholar]
  3. De Matteis, M.A.; Godi, A. PI-loting membrane traffic. Nat. Cell Biol. 2004, 6, 487–492. [Google Scholar] [CrossRef]
  4. Christopher, L.C.; Lewis, C.C. Phosphoinositide kinases. Curr. Opin. Cell Biol. 1996, 8, 153–158. [Google Scholar]
  5. Nakagawa, T.; Goto, K.; Konda, H. Cloning, expression and localization of 230 kDa phosphatidylinositol 4-kinase. J. Biol. Chem. 1996, 271, 12088–12094. [Google Scholar] [CrossRef] [PubMed]
  6. Nakagawa, T.; Goto, K.; Konda, H. Cloning and characterization of a 92kDa soluble phosphatidylinositol 4-kinase. Biochem. J. 1996, 320, 643–649. [Google Scholar] [CrossRef]
  7. Gracia-Bustos, J.F.; Marini, F.; Stevenson, I.; Feri, C.; Hall, M.N. PIK1, an essential phosphatidylinositol 4-kinase associated with the yeast nucleus. EMBO J. 1994, 13, 2352–2361. [Google Scholar] [CrossRef]
  8. Yoshida, S.; Ohya, Y.; Giebl, M.; Nakano, A.; Anraku, Y.J. A novel gene STT4 encodes a phosphatidylinositol 4-kinase in the PKC1 protein kinase pathway of Saccharomyces cerevisiae. J. Biol. Chem. 1994, 269, 1166–1172. [Google Scholar] [CrossRef]
  9. Balla, T.; Downing, G.J.; Jaffe, H.; Kim, S.; Zolyomi, A. Isolation and molecular cloning of wortmannin-sensitive bovine type III phosphatidylinositol 4-kinase. J. Biol. Chem. 1997, 272, 18358–18366. [Google Scholar] [CrossRef]
  10. Gehrmann, T.; Vereb, G.; Schimdt, M.; Klix, D.; Meyer, H.E.; Varsanyi, M.; Heilmeyer, L.M.G., Jr. Identification of 200 kDa polypeptide as type 3 phosphatidylinositol 4-kinase from bovine brain by partial protein and cDNA sequencing. Biochim. Biophys. Acta 1996, 1311, 53–63. [Google Scholar] [CrossRef]
  11. Endemann, G.C.; Graziani, A.; Cantley, L.C. A monoclonal antibody distinguishes two types of phosphatidylinositol 4-kinase. Biochem.J. 1991, 273 Pt 1, 63–66. [Google Scholar] [CrossRef]
  12. Barylko, B.; Gerber, S.H.; Binns, D.D.; Grichine, N.; Khvotchev, M.; Sudhof, T.C.; Albanesi, J.P. A novel family of phosphatidylinositol 4-kinases conserved from yeast to humans. J. Biol. Chem. 2001, 276, 7705–7708. [Google Scholar] [CrossRef] [PubMed]
  13. Minogue, S.; Anderson, J.S.; Waugh, M.G.; dos Santos, M.; Corless, S.; Cramer, R.; Hsuan, J.J. Cloning of a human type II phosphatidylinositol 4-kinase reveals a novel lipid kinase family. J. Biol. Chem. 2001, 276, 16635–16640. [Google Scholar] [CrossRef] [PubMed]
  14. Balla, A.; Tuymetova, G.; Barshishat, M.; Geiszt, M.; Balla, T. Characterization of type II phosphatidylinositol 4-kinase isoforms reveals association of the enzyme with endosomal vesicular compartment. J. Biol. Chem. 2002, 277, 20041–20050. [Google Scholar] [CrossRef] [PubMed]
  15. Flanagan, C.A.; Thorner, J. Purification and characterization of a soluble phosphatidylinositol 4-kinase from the yeast Saccharomyces cerevisiae. J. Biol. Chem. 1992, 267, 24117–24125. [Google Scholar] [CrossRef]
  16. Nakanishi, S.; Catt, J.K.; Balla, T. A wortmannin—sensitive phosphatidylinositol 4—kinase that regulates hormone sensitive pools of inositolphospholipids. Proc. Natl. Acad. Sci. USA 1995, 92, 5317–5321. [Google Scholar] [CrossRef]
  17. Zólyomi, A.; Zhao, X.; Downing, G.J.; Balla, T. Localization of two distinct type III phosphatidylinositol 4-kinase enzyme mRNAs in the rat. Am. J. Physiol. Cell Physiol. 2000, 278, C914–C920. [Google Scholar] [CrossRef] [PubMed]
  18. Guo, J.; Wenk, M.R.; Pellegrini, L.; Onofri, F.; Benfenati, F.; De Camilli, P. Phosphatidylinositol 4-kinase type IIalpha is responsible for the phosphatidylinositol 4-kinase activity associated with synaptic vesicles. Proc. Natl. Acad. Sci. USA 2003, 100, 3995–4000. [Google Scholar] [CrossRef]
  19. Ivetac, I.; Munday, A.D.; Kisseleva, M.V.; Zhang, X.M.; Luff, S.; Tiganis, T.; Whisstock, J.C.; Rowe, T.; Majerus, P.W.; Mitchell, C.A. The type I alpha inositol polyphosphate 4-phosphatase generates and terminates phosphoinositide 3-kinase signals on endosomes and the plasma membrane. Mol. Biol. Cell. 2005, 16, 2218–2233. [Google Scholar] [CrossRef]
  20. Boura, E.; Nencka, R. Phosphatidylinositol 4-kinases: Function, structure, and inhibition. Exp. Cell Res. 2015, 337, 136–145. [Google Scholar] [CrossRef]
  21. Baumlova, A.; Chalupska, D.; Róźycki, B.; Jovic, M.; Wisniewski, E.; Klima, M.; Dubankova, A.; Kloer, D.P.; Nencka, R.; Balla, T.; et al. The crystal structure of the phosphatidylinositol 4-kinase IIα. EMBO Rep. 2014, 15, 1085–1092. [Google Scholar] [CrossRef] [PubMed]
  22. Klima, M.; Baumlova, A.; Chalupska, D.; Hřebabecký, H.; Dejmek, M.; Nencka, R.; Boura, E. The high-resolution crystal structure of phosphatidylinositol 4-kinase IIβ and the crystal structure of phosphatidylinositol 4-kinase IIα containing a nucleoside analogue provide a structural basis for isoform-specific inhibitor design. Acta Crystallogr. D Biol. Crystallogr. 2015, 71, 1555–1563. [Google Scholar] [CrossRef] [PubMed]
  23. Misehe, M.; Klima, M.; Matoušová, M.; Chalupská, D.; Dejmek, M.; Šála, M.; Mertlíková-Kaiserová, H.; Boura, E.; Nencka, R. Structure-based design and modular synthesis of novel PI4K class II inhibitors bearing a 4-aminoquinazoline scaffold. Bioorg. Med. Chem. Lett. 2022, 76, 129010. [Google Scholar] [CrossRef] [PubMed]
  24. Fienberg, S.; Eyermann, C.J.; Arendse, L.B.; Basarab, G.S.; McPhail, J.A.; Burke, J.E.; Chibale, K. Structural Basis for Inhibitor Potency and Selectivity of Plasmodium falciparum Phosphatidylinositol 4-Kinase Inhibitors. ACS Infect. Dis. 2020, 6, 3048–3063. [Google Scholar] [CrossRef]
  25. Wang, Y.J.; Wang, J.; Sun, H.Q.; Martinez, M.; Sun, Y.X.; Macia, E.; Kirchhausen, T.; Albanesi, J.P.; Roth, M.G.; Yin, H.L. Phosphatidylinositol 4 phosphate regulates targeting of clathrin adaptorAP-1 complexes to the Golgi. Cell 2003, 114, 299–310. [Google Scholar] [CrossRef] [PubMed]
  26. Waugh, M.G.; Minogue, S.; Anderson, J.S.; Balinger, A.; Blumenkrantz, D.; Calnan, D.P.; Cramer, R.; Hsuan, J.J. Localization of a highly active pool of type II phosphatidylinositol 4-kinase in a p97/valosin-containing-protein-rich fraction of the endoplasmicreticulum. Biochem. J. 2003, 373, 57–63. [Google Scholar] [CrossRef] [PubMed]
  27. Kakuk, A.; Friedländer, E.; Vereb, G., Jr.; Kása, A.; Balla, A.; Balla, T.; Heilmeyer, L.M., Jr.; Gergely, P.; Vereb, G. Nucleolar localization of phosphatidyl inositol 4-kinasePI4K230 in various mammalian cells. Cytometry A 2006, 69, 1174–1183. [Google Scholar] [CrossRef]
  28. Balla, A.; Vereb, G.; Gülkan, H.; Gehrmann, T.; Gergely, P.; Heilmeyer, L.M., Jr.; Antal, M. Immunohistochemical localization of two phosphatidylinositol 4-kinase Isoforms, PI4K230 and PI4K92, in the central nervous system of rats. Exp. Brain. Res. 2000, 134, 279–288. [Google Scholar] [CrossRef]
  29. Szivak, I.; Lamb, N.; Heilmeyer, L.M. Subcellular localization and structural function of endogenous phosphorylated phos-phatidylinositol 4-kinase (PI4K92). J. Biol. Chem. 2006, 281, 16740–16749. [Google Scholar] [CrossRef]
  30. Bianco, A.; Reghellin, V.; Donnici, L.; Fenu, S.; Alvarez, R.; Baruffa, C.; Peri, F.; Pagani, M.; Abrignani, S.; Neddermann, P.; et al. Metabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P Is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity. PLoS Pathog. 2012, 8, e1002576. [Google Scholar] [CrossRef]
  31. Kong, D.; Yamori, T. Advances in development of phosphatidylinositol 3-kinase inhibitors. Curr. Med. Chem. 2009, 16, 2839–2854. [Google Scholar] [CrossRef] [PubMed]
  32. Thor, G.; Gulkan, H.; Suer, S.; Herberg, F.W.; Balla, A.; Vereb, G.; Mayer, G.W.; Heilmeyer, L.M.G., Jr. Functional expression and characterisation of new human phosphatidylinositol 4- kinase PI4K230. Biochim. Biophys. Acta 1999, 1437, 341–356. [Google Scholar]
  33. Carrasco, D.; Jacob, G.; Allende, C.C.; Allende, J.E. Polylysine and polyamine stimulation of the phosphatidylinositol kinases of amphibian oocytes membranes. Biochem. Int. 1988, 17, 319–327. [Google Scholar] [PubMed]
  34. Vogel, S.; Hoppe, J. Polyamines stimulate the phosphorylation of phosphatidylinositol in membranes from A431 cells. Europ. J. Biochem. 1986, 154, 253–257. [Google Scholar] [CrossRef] [PubMed]
  35. Smith, C.D.; Synderman, R. Modulation of inositol phospholipid metabolism by polyamines. Biochem. J. 1988, 256, 125–130. [Google Scholar] [CrossRef] [PubMed]
  36. Lundberg, G.A.; Sundler, R.; Jergil, B. Activation of phosphatidylinositol-4-phosphate kinase in rat liver plasma membranes by polyamines. Biochim. Biophys. Acta 1987, 922, 1–7. [Google Scholar] [CrossRef] [PubMed]
  37. Lo, T.N.; Eng, S.P.; Jaseph, L.A.; Beaven, M.A.; Lo, C.S. Cardiotoxin from cobra venom increases the level of phosphatidylinositol 4-monophosphate and phosphatidylinositol kinase activity in two cell lines. Biochim. Biophys. Acta 1988, 970, 51–60. [Google Scholar] [CrossRef] [PubMed]
  38. Walker, D.H.; Pike, L.J. Stimulation of purified phosphatidylinositol 4-kinase by cobra venom cardiotoxin. Biochim. Biophys. Acta 1990, 1055, 295–298. [Google Scholar] [CrossRef]
  39. Eng, S.P.; Lo, C.S. Mastoparan increases membrane bound phosphatidylinositol kinase and phosphatidylinositol 4-monophosphate kinase activities in Madin-Darby canine kidney cells. Life Sci. 1990, 46, 273–279. [Google Scholar] [CrossRef]
  40. Chen, Y.; Yang, D.C.; Brown, A.B.; Jeng, Y.; Tatoyan, A.; Chan, T.M. Activation of a membrane associated phosphatidylinositol kinase through tyrosine-protein phosphorylation by naphthoquinones and orthovandate. Arch. Biochem. Biophys. 1990, 283, 184–192. [Google Scholar] [CrossRef]
  41. Scott, G.K.; Dodson, J.M.; Montogomery, P.A.; Johnson, R.M.; Sarup, J.C.; Wong, W.L.; Ullrich, A.; Sheperd, H.M.; Benz, C.C. p185HER2 signal transduction in breast cancer cells. J. Biol. Chem. 1991, 266, 14300–14305. [Google Scholar] [CrossRef] [PubMed]
  42. Walker, D.H.; Pike, L.J. Phosphatidylinositol kinase is activated in membranes derived from cells treated with epidermal growth factor. Proc. Natl. Acad. Sci. USA 1987, 84, 7513–7517. [Google Scholar] [CrossRef] [PubMed]
  43. Einicker-Lamas, M.; Wenceslau, L.D.; Bernardo, R.; Nogaroli, L.; Guilheme, A.; Oliveria, M.M.; Vieyra, A. Sphingosine 1-phosphate formation activates phosphatidylinositol 4-kinase in blasolateral membranes from kidney cells: Crosstalk in cell signalling through sphingolipids and phospholipids. J. Biochem. 2003, 134, 529–536. [Google Scholar] [CrossRef] [PubMed]
  44. Jenkins, G.H.; Subrahmanyam, G.; Anderson, R.A. Purification and reconstitution of phosphatidylinositol 4-kinase from human erythrocytes. Biochim. Biophys. Acta 1991, 1080, 11–18. [Google Scholar] [CrossRef] [PubMed]
  45. Naito, T.; Nakagawa, S.; Okita, T.A.; Yamashita, H.; Yamashita, T.; Kamei, H.; Tomatsu, K.; Imanishi, H.; Kawaguchi, H. Synthesis and bronchodilating activity of 2, 9 disubstituted adenine derivatives BB-1502 (9-cyclohexyl-2-n-propoxy-9H- adenine) and its analogs. Chem. Parm. Bull. 1982, 30, 2011–2019. [Google Scholar] [CrossRef] [PubMed]
  46. Nishioka, H.; Imoto, M.; Sawa, T.; Hamada, M.; Naganawa, H.; Takeuchi, T.; Umezawa, K. Screening of phosphatidylinositol kinase inhibitors from Streptomyces. J. Antibiot. 1989, 42, 823–825. [Google Scholar] [CrossRef] [PubMed]
  47. Porter, F.D.; Li, Y.-S.; Deuel, T.F. Purification and characterization of a phosphatidylinositol 4-kinase from bovine uteri. J. Biol. Chem. 1988, 263, 8989–8995. [Google Scholar] [CrossRef] [PubMed]
  48. Hashizume, T.; Nakao, M.; Sato, T. Sphingosine enhances phosphatidylinositol 4-kinase activity in rabbit platelets. J. Biochem. 1996, 120, 61–65. [Google Scholar] [CrossRef] [PubMed]
  49. Scholz, G.; Baritt, G.J.; Kwok, F. Purification and chemical modification of a phosphatidylinositol kinase from sheep brain. Eur. J. Biochem. 1991, 201, 249–255. [Google Scholar] [CrossRef]
  50. Wetzker, R.; Klinger, R.; Hsuan, J.; Fry, M.J.; Kauffnmann-Zeh, A.; Muller, E.; Frunder, H.; Waterfield, M. Purification and characterization of phosphatidylinositol 4-kinase from human erythrocyte membranes. Eur. J. Bioch. 1991, 200, 179–185. [Google Scholar] [CrossRef]
  51. Katso, R.; Okkenhaug, K.; Ahmadi, K.; White, S.; Timms, J.; Waterfield, M.D. Cellular function of phosphoinositide 3-kinases; implications for development, homeostasis and cancer. Annu. Rev. Cell. Dev. Biol. 2001, 17, 615–675. [Google Scholar] [CrossRef] [PubMed]
  52. Engelman, J.A.; Luo, J.; Cantley, L.C. The evolution of phosphoinositide 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 2006, 6, 606–619. [Google Scholar] [CrossRef] [PubMed]
  53. Datta, S.R.; Brunet, A.; Greenberg, M.E. Cellular survival: A play in three Akts. Genes. Dev. 1999, 13, 2905–2927. [Google Scholar] [CrossRef] [PubMed]
  54. Brazil, D.P.; Yang, Z.; Hemmings, B.A. Advances in protein kinase B signalling: AKT action on multiple fronts. Trends Biochem. Sci. 2004, 29, 233–242. [Google Scholar] [CrossRef] [PubMed]
  55. Brugge, J.; Hung, M.C.; Mills, G.B. A new mutational AKT activation in the PI3K pathway. Cancer Cell 2007, 12, 104–107. [Google Scholar] [CrossRef] [PubMed]
  56. Cardone, M.H.; Roy, N.; Stennicke, H.R.; Salvesen, G.S.; Franke, T.F.; Stanbridge, E.; Frisch, S.; Reed, J.C. Regulation of cell death protease caspase-9 by phosphorylation. Science 1988, 282, 1318–1321. [Google Scholar] [CrossRef]
  57. Li, G.; Wu, Y.; Zhang, Y.; Wang, H.; Li, M.; He, D.; Guan, W.; Yao, H. Research progress on phosphatidylinositol 4-kinase inhibitors. Biochem. Pharmacol. 2024, 220, 115993. [Google Scholar] [CrossRef] [PubMed]
  58. Aberle, H.; Bauer, A.; Stappert, J.; Kispert, A.; Kemler, R. β-catenin is a target for the ubiquitin proteasome pathway. EMBO J. 1997, 16, 3797–3804. [Google Scholar] [CrossRef] [PubMed]
  59. Nteliopoulos, G.; Marley, S.B.; Gordon, M.Y. Influence of PI-3K/Akt pathway on Wnt signalling in regulating myeloid progenitor cell proliferation. Evidence for a role of autocrine/paracrine Wnt regulation. Br. J. Haematol. Res. Pap.
  60. Xu, L.; Corcoran, R.B.; Welsh, J.W.; Pennica, D.; Levine, A.J. WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. Genes Dev. 2000, 14, 585–595. [Google Scholar] [CrossRef] [PubMed]
  61. He, T.C.; Sparks, A.B.; Rago, C.; Hermeking, H.; Zawel, L.; da Costa, L.T.; Morin, P.J.; Vogelstein, B.; Kinzler, K.W. Identification of c-MYC as a target of the APC pathway. Science 1998, 281, 1509–1512. [Google Scholar] [CrossRef]
  62. Roose, J.; Clevers, H. TCF transcription factors: Molecular switches in carcinogenesis. Biochim. Biophys. Acta 1999, 1424, M23–M37. [Google Scholar] [CrossRef]
  63. Mann, B.; Gelos, M.; Siedow, A.; Hansk, I.M.; Gratchev, A.; Ilyas, M.; Bodmer, W.; Moyer, M.; Riecken, E.; Buhr, H. Target genes of betacatenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc. Natl. Acad. Sci. USA 1999, 96, 1603–1608. [Google Scholar] [CrossRef] [PubMed]
  64. Hart, M.; Concordet, J.; Lassot, I.; Albert, I.; del los Santos, R.; Durand, H.; Perret, C.; Rubinfeld, B.; Margottin, F.; Benarous, R.; et al. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr. Biol. 1999, 9, 207–210. [Google Scholar] [CrossRef] [PubMed]
  65. Burns, T.F.; El-Deiry, W.S. The p53 pathway and apoptosis. J. Cell. Physiol. 1999, 181, 231–239. [Google Scholar] [CrossRef]
  66. el-Deiry, W.S. Regulation of p53 downstream genes. Semin. Cancer Biol. 1998, 8, 345–357. [Google Scholar] [CrossRef] [PubMed]
  67. Berridge, M.J.; Irvine, R.F. Inositol phosphates and cell signalling. Nature 1989, 21, 197–205. [Google Scholar] [CrossRef] [PubMed]
  68. O’Brian, C.; Vogel, V.G.; Singletary, S.E.; Ward, N.E. Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res. 1989, 49, 3215–3217. [Google Scholar]
  69. Kopp, R.; Noelke, B.; Sauter, G.; Schildberg, F.W.; Paumgartner, G.; Pfeiffer, A. Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas. Cancer Res. 1991, 51, 205–210. [Google Scholar] [PubMed]
  70. Stossel, T.P. On the crawling of animal cells. Science 1993, 260, 1086–1094. [Google Scholar] [CrossRef] [PubMed]
  71. Schafer, D.A.; Jennings, P.B.; Cooper, J.A. Dynamics of capping protein and actin assembly in vitro: Uncapping barbed ends by polyphosphoinositides. J. Cell Biol. 1996, 135, 169–179. [Google Scholar] [CrossRef]
  72. Carol, O.A.; Carpen, O. A actinin revisited: A fresh look at an old player. Cell Motil. Cytoskelet. 2004, 58, 104–111. [Google Scholar]
  73. Yarmola, G.E.; Bubb, M.R. How depolymerization can promote polymerization: The case of actin and profilin. Bioassays 2009, 31, 1150–1160. [Google Scholar] [CrossRef] [PubMed]
  74. Gilmore, A.P.; Burridge, K. Regulation of vinculin binding to talin and actin by phosphatidylinositol 4,5-bisphosphate. Nature 1996, 381, 531–535. [Google Scholar] [CrossRef] [PubMed]
  75. Di Paolo, G.; De Camilli, P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006, 443, 651–657. [Google Scholar] [CrossRef] [PubMed]
  76. Hausser, A.; Link, G.; Hoene, M.; Russo, C.; Selchow, O.; Pfizenmaier, K. Phospho-specific binding of 14-3-3 proteins to phosphatidylinositol 4-kinase III beta protects from dephosphorylation and stabilizes lipid kinase activity. J. Cell Sci. 2006, 119 Pt 17, 3613–3621. [Google Scholar] [CrossRef]
  77. Chalupska, D.; Eisenreichova, A.; Różycki, B.; Rezabkova, L.; Humpolickova, J.; Klima, M.; Boura, E. Structural analysis of phosphatidylinositol 4-kinase IIIβ (PI4KB)—14-3-3 protein complex reveals internal flexibility and explains 14-3-3 mediated protection from degradation in vitro. J. Struct. Biol. 2017, 200, 36–44. [Google Scholar] [CrossRef] [PubMed]
  78. Demmel, L.; Beck, M.; Klose, C.; Schlaitz, A.L.; Gloor, Y.; Hsu, P.P.; Havlis, J.; Shevchenko, A.; Krause, E.; Kalaidzidis, Y.; et al. Nucleocytoplasmic shuttling of the Golgi phosphatidylinositol 4-kinase Pik1 is regulated by 14-3-3 proteins and coordinates Golgi function with cell growth. Mol. Biol. Cell. 2008, 19, 1046–1061. [Google Scholar] [CrossRef] [PubMed]
  79. Kumar, R. Differential abundance and transcription of 14-3-3 proteins during vegetative growth and sexual reproduction in budding yeast. Sci. Rep. 2018, 8, 2145. [Google Scholar] [CrossRef] [PubMed]
  80. Kumar, R. An account of fungal 14-3-3 proteins. Eur. J. Cell Biol. 2017, 96, 206–217. [Google Scholar] [CrossRef] [PubMed]
  81. STT4/YLR305C Interactions, 2024. Available online: https://www.yeastgenome.org/locus/S000004296/interaction (accessed on 28 May 2024).
  82. PIK1/YNL267W Interactions, 2024. Available online: https://www.yeastgenome.org/locus/S000005211/interaction (accessed on 28 May 2024).
  83. Anne, S.; Wurmser, A.E.; Emr, S.D.; Stenmark, H. The role of phosphoinositides in membrane transport. Curr. Opin. Cell Biol. 2001, 13, 485–492. [Google Scholar]
  84. Ma, H.; Blake, T.; Chitnis, A.; Liu, P.; Balla, T. Crucial role of phosphatidylinositol 4-kinase III α in development of zebrafish pectoral fin is linked to phosphoinositide 3-kinase FGF signaling. J. Cell Sci. 2009, 122, 4303–4310. [Google Scholar] [CrossRef]
  85. Balla, A.; Kim, Y.J.; Varni, P.; Szentpetery, Z.; Knight, Z.; Shokat, K.M.; Balla, T. Maintenance of hormone—Sensitive phosphoinositide pools in the plasma membrane require phosphatidylinositol 4-kinase III alpha. Mol. Biol. Cell 2008, 19, 711–721. [Google Scholar] [CrossRef] [PubMed]
  86. Berger, K.L.; Cooper, J.D.; Heaton, N.S.; Yoon, R.; Oakland, T.E.; Jordan, T.X.; Mateu, G.; Grakoui, A.; Randall, G. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication. Proc. Natl. Acad. Sci. USA 2009, 106, 75577–75582. [Google Scholar] [CrossRef] [PubMed]
  87. Simons, J.P.; Al-Shwai, R.; Miongue, S.; Waugh, M.; Wiedmenn, C.; Evangelou, S.; Loesch, A.; Sihra, T.S.; King, R.; Warner, T.T.; et al. Loss of phosphatidylinositol 4-kinase 2 alpha activity cause late onset degeneration of spinal cord axons. Proc. Natl. Acad. Sci. USA 2009, 106, 11535–11539. [Google Scholar] [CrossRef] [PubMed]
  88. Li, J.; Lu, Y.; Zhang, J.; Kan, G.H.; Qin, Z.; Chen, C. PI4KIIα is a novel regulator of tumor growth by its action on angiogenesis and HIF-1α regulation. Oncogene 2010, 29, 2550–2559. [Google Scholar] [CrossRef] [PubMed]
  89. Pan, W.; Choi, S.C.; Wang, H.; Qin, Y.; Volpicelli-Daley, L.; Swan, L.; Lucast, L.; Khoo, C.; Zhang, X.; Li, L.; et al. Wnt 3a mediated formation of phosphatidylinositol 4, 5-bisphosphate regulates LRP6 phosphorylation. Science 2008, 321, 1350–1353. [Google Scholar] [CrossRef] [PubMed]
  90. Qin, Y.; Li, L.; Pan, W.; Wu, D. Regulation of phosphatidylinositol kinases and metabolism by Wnt3a and Dvl2. J. Biol. Chem. 2009, 284, 22544–222548. [Google Scholar] [CrossRef] [PubMed]
  91. Xu, Z.; Huang, G.; Kandror, K.V. Phosphatidylinositol 4-kinase type II alpha is targeted specifically to cellugyrin-positive glucose transporter 4 vesicles. Mol. Endocrinol. 2006, 20, 2890–2897. [Google Scholar] [CrossRef] [PubMed]
  92. Minogue, S.; Waugh, M.G.; De Matteis, M.A.; Stephens, D.J.; Berditchevski, F.; Hsuan, J.J. Phosphatidylinositol 4-kinase is required for endosomal trafficking and degradation of the EGF receptor. J. Cell Sci. 2006, 119, 571–581. [Google Scholar] [CrossRef] [PubMed]
  93. Craige, B.; Salazar, G.; Faundez, V. Phosphatidylinositol-4-kinase type II alpha contains an AP-3-sorting motif and a kinase domain that are both required for endosome traffic. Mol. Biol. Cell 2008, 19, 1415–1426. [Google Scholar] [CrossRef]
  94. Liscovitch, M. Phospholipase D: Role in signal transduction and membrane traffic. J. Lipid Mediat. Signal. 1996, 14, 215–221. [Google Scholar] [CrossRef]
  95. Chang, F.S.; Han, G.S.; Carman, G.S.; Blumer, K.J. A WASp binding type II phosphatidylinositol 4-kinase required for actin polymerization driven endosome motility. J. Cell. Biol. 2005, 171, 133–142. [Google Scholar] [CrossRef] [PubMed]
  96. Srivastava, R.; Ratheesh, A.; Gude, R.K.; Roa, K.V.; Panda, D.; Subrahmanyam, G. Resveratol inhibits type II phosphatidylinositol 4-kinase: A key component in pathways of phosphoinositide turnover. Biochem. Pharmacol. 2005, 70, 1048–1055. [Google Scholar] [CrossRef] [PubMed]
  97. Pizarro-Cerda, J.; Payrastre, B.; Wang, Y.J.; Veiga, E.; Yin, H.L.; Cossart, P. Type II phosphatidylinositol 4-kinase promotes Listeria monocytogenes entry into target cells. Cell Microbiol. 2007, 9, 2381–2390. [Google Scholar] [CrossRef] [PubMed]
  98. Yue, J.; Liu, J.; Shen, X. Inhibition of phosphatidylinositol 4-kinase results in a significant reduced respiratory brust in formyl-methionyl-leucyl-phenylalanine-stimulated human Neutrophils. J. Biol. Chem. 2001, 276, 49093–49099. [Google Scholar] [CrossRef] [PubMed]
  99. Naveen, B.; Shanker, B.S.; Subrahmanyam, G. Fcepsilon RI crossliking activates a type II phosphatidylinositol 4-kinase in RBL2H3cells. Mol. Immunol. 2005, 42, 1541–1549. [Google Scholar] [CrossRef]
  100. Ishihara, Y.; Furuno, T.; Nakanishi, M. The role of phosphatidylinositol 4-kinase II alpha in degranulation of RBL2H3 cells. Inflamm. Res. 2006, 55, 465–468. [Google Scholar] [CrossRef] [PubMed]
  101. Wiedemann, C.; Schafer, T.; Burger, M.M. Chromaffin granule-associated phosphatidylinositol 4-kinase activity is required for stimulated secretion. EMBO J. 1996, 15, 2094–2101. [Google Scholar] [CrossRef] [PubMed]
  102. Gibon, J.; Buckley, S.M.; Unsain, N.; Kaartinen, V.; Séguéla, P.; Barker, P.A. proBDNF and p75NTR Control Excitability and Persistent Firing of Cortical Pyramidal Neurons. J. Neurosci. 2015, 35, 9741–9753. [Google Scholar] [CrossRef]
  103. Akhter, S.; Uddin, M.N.; Jeong, I.S.; Kim, D.W.; Liu, X.M.; Bahk, J.D. Role of Arabidopsis AtPI4Kγ3, a type II phosphoinositide 4-kinase, in abiotic stress responses and floral transition. Plant Biotechnol. J. 2015, 14, 215–230. [Google Scholar] [CrossRef] [PubMed]
  104. Okazaki, K.; Miyagishima, S.Y.; Wada, H. Phosphatidylinositol 4-phosphate negatively regulates chloroplast division in Arabidopsis. Plant Cell 2015, 27, 663–674. [Google Scholar] [CrossRef]
  105. Antignani, V.; Klocko, A.L.; Bak, G.; Chandrasekaran, S.D.; Dunivin, T.; Nielsen, E. Recruitment of PLANT U-BOX13 and the PI4Kβ1/β2 phosphatidylinositol-4 kinases by the small GTPase RabA4B plays important roles during salicylic acid-mediated plant defense signaling in Arabidopsis. Plant Cell 2015, 27, 243–261. [Google Scholar] [CrossRef] [PubMed]
  106. Wang, K.; Yang, Z.; Liu, X.; Mao, K.; Nair, U.; Klionsky, D.J. Phosphatidylinositol 4-kinases are required for autophagic membrane trafficking. J. Biol. Chem. 2012, 287, 37964–37972. [Google Scholar] [CrossRef] [PubMed]
  107. Chaudhry, S.; Joshi, V.; Bojjireddy, N.; Thoh, M.; Sandur, S.K.; Subrahmanyam, G. Silencing of type II phosphatidylinositol 4-kinase β stabilizes prostate apoptosis response-4 and induces apoptosis in cancer cells. Biochem. J. 2019, 476, 405–419. [Google Scholar] [CrossRef] [PubMed]
  108. Zhao, H.; Kong, F.; Yu, W.; Zhao, H.; Zhang, J.; Zhou, J.; Meng, X. Locational and functional characterization of PI4KB in the mouse embryo. J. Cell Physiol. 2024, 239, e31195. [Google Scholar] [CrossRef] [PubMed]
  109. Koester, A.M.; Geiser, A.; Laidlaw, K.M.E.; Morris, S.; Cutiongco, M.F.A.; Stirrat, L.; Gadegaard, N.; Boles, E.; Black, H.L.; Bryant, N.J.; et al. EFR3 and phosphatidylinositol 4-kinase IIIα regulate insulin-stimulated glucose transport and GLUT4 dispersal in 3T3-L1 adipocytes. Biosci. Rep. 2022, 42, BSR20221181. [Google Scholar] [CrossRef] [PubMed]
  110. Delang, L.; Harak, C.; Benkheil, M.; Khan, H.; Leyssen, P.; Andrews, M.; Lohmann, V.; Neyts, J. PI4KIII inhibitor enviroxime impedes the replication of the hepatitis C virus by inhibiting PI3 kinases. J. Antimicrob. Chemother. 2018, 73, 3375–3384. [Google Scholar] [CrossRef] [PubMed]
  111. Highland, C.M.; Fromme, J.C. Arf1 directly recruits the Pik1-Frq1 PI4K complex to regulate the final stages of Golgi maturation. Mol. Biol. Cell. 2021, 32, 1064–1080. [Google Scholar] [CrossRef] [PubMed]
  112. Chen, L.; Zhang, L.; Mei, X.; Wang, C.; Guo, Z.; Li, L.; Li, B.; Liang, Y.; Zou, S.; Dong, H. The type II phosphoinositide 4-kinase FgLsb6 is important for the development and virulence of Fusarium graminearum. Fungal Genet. Biol. 2020, 144, 103443. [Google Scholar] [CrossRef] [PubMed]
  113. Mansi Kushwaha, N.K.; Singh, A.K.; Karim, M.J.; Chakraborty, S. Nicotiana benthamiana phosphatidylinositol 4-kinase type II regulates chilli leaf curl virus pathogenesis. Mol. Plant Pathol. 2019, 20, 1408–1424. [Google Scholar] [CrossRef]
  114. Lin, F.; Krishnamoorthy, P.; Schubert, V.; Hause, G.; Heilmann, M.; Heilmann, I. A dual role for cell plate-associated PI4Kβ in endocytosis and phragmoplast dynamics during plant somatic cytokinesis. EMBO J. 2019, 38, e100303. [Google Scholar] [CrossRef]
Encyclopedia 04 00068 g001
Figure 1. Structure of Phosphatidylinositol lipid. Hydroxyl (-OH) group phosphorylated by phosphatidylinositol 4- kinases is marked in rectangular box. R1, R2 represents sn-1, sn-2 acyl chains respectively. Red colour represents phosphate group.
Figure 1. Structure of Phosphatidylinositol lipid. Hydroxyl (-OH) group phosphorylated by phosphatidylinositol 4- kinases is marked in rectangular box. R1, R2 represents sn-1, sn-2 acyl chains respectively. Red colour represents phosphate group.
Encyclopedia 04 00068 g001
Table 1. Various roles of phosphatidyl inositol 4-kinase.
Table 1. Various roles of phosphatidyl inositol 4-kinase.
S. No.SpeciesFunction/Role in different cellular processReferences
01Mus musculusPersistent Firing of Cortical Pyramidal Neurons[102]
02Arabidopsis thalianaResistant against abiotic stress and delay of floral transition [103]
03Arabidopsis thalianaRegulation of chloroplast division [104]
04Arabidopsis thalianaPlant defense mechanism[105]
05S. cerevisiaeAutophagy[106]
06MCF-7 cell lineApoptosis[107]
07Mus musculusEmbryo development[108]
083T3-L1 adipocytesGlucose transporters mobilization [109]
09HPV-CViral replication[110]
10Pichia pastorisGolgi maturation/formation[111]
12Fusarium graminearumFungal infection/pathogenesis in plants[112]
13Nicotiana benthamianaViral infection in plants[113]
14Arabidopsis thalianaCytokinesis[114]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kumar, R.; Kumar, P. Phosphatidyl Inositol 4-Kinases. Encyclopedia 2024, 4, 1062-1072. https://doi.org/10.3390/encyclopedia4030068

AMA Style

Kumar R, Kumar P. Phosphatidyl Inositol 4-Kinases. Encyclopedia. 2024; 4(3):1062-1072. https://doi.org/10.3390/encyclopedia4030068

Chicago/Turabian Style

Kumar, Ravinder, and Piyush Kumar. 2024. "Phosphatidyl Inositol 4-Kinases" Encyclopedia 4, no. 3: 1062-1072. https://doi.org/10.3390/encyclopedia4030068

APA Style

Kumar, R., & Kumar, P. (2024). Phosphatidyl Inositol 4-Kinases. Encyclopedia, 4(3), 1062-1072. https://doi.org/10.3390/encyclopedia4030068

Article Metrics

Back to TopTop